ATE402172T1 - Thioetherderivate, deren herstellung und verwendung als pharmazeutische mittel - Google Patents

Thioetherderivate, deren herstellung und verwendung als pharmazeutische mittel

Info

Publication number
ATE402172T1
ATE402172T1 AT05750944T AT05750944T ATE402172T1 AT E402172 T1 ATE402172 T1 AT E402172T1 AT 05750944 T AT05750944 T AT 05750944T AT 05750944 T AT05750944 T AT 05750944T AT E402172 T1 ATE402172 T1 AT E402172T1
Authority
AT
Austria
Prior art keywords
preparation
pharmaceutical products
thioether derivatives
thioether
derivatives
Prior art date
Application number
AT05750944T
Other languages
English (en)
Inventor
Birgit Bossenmaier
Walter-Gunar Friebe
Thomas Friess
Lothar Kling
Ulrike Reiff
Edgar Voss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35063231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE402172(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE402172T1 publication Critical patent/ATE402172T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05750944T 2004-05-25 2005-05-24 Thioetherderivate, deren herstellung und verwendung als pharmazeutische mittel ATE402172T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04012294 2004-05-25
EP04029138 2004-12-09

Publications (1)

Publication Number Publication Date
ATE402172T1 true ATE402172T1 (de) 2008-08-15

Family

ID=35063231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05750944T ATE402172T1 (de) 2004-05-25 2005-05-24 Thioetherderivate, deren herstellung und verwendung als pharmazeutische mittel

Country Status (13)

Country Link
US (1) US7005526B2 (de)
EP (1) EP1761525B1 (de)
JP (1) JP2008500298A (de)
AR (1) AR049343A1 (de)
AT (1) ATE402172T1 (de)
AU (1) AU2005247588A1 (de)
BR (1) BRPI0511523A (de)
CA (1) CA2565257A1 (de)
DE (1) DE602005008433D1 (de)
MX (1) MXPA06013321A (de)
RU (1) RU2006145895A (de)
TW (1) TW200633701A (de)
WO (1) WO2005116019A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247649B2 (en) * 2003-08-13 2007-07-24 Hoffmann-La Roche Inc. Oxazoles, their manufacture and use as pharmaceutical agents
CA2995617A1 (en) 2017-11-03 2019-05-03 Universite De Montreal Heterocyclic mitochondrial activity inhibitors and uses thereof
CN118767143A (zh) 2019-12-12 2024-10-15 听治疗有限责任公司 用于预防和治疗听力损失的组合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003505A2 (en) 1996-07-19 1998-01-29 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
US6984653B2 (en) 2001-10-05 2006-01-10 Takeda Pharmaceutical Company Limited Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
JP2003277379A (ja) * 2002-01-17 2003-10-02 Takeda Chem Ind Ltd 含窒素複素環化合物、その製造法および用途
AU2003203170A1 (en) 2002-01-17 2003-07-30 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
TW200505913A (en) 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents

Also Published As

Publication number Publication date
TW200633701A (en) 2006-10-01
WO2005116019A1 (en) 2005-12-08
AR049343A1 (es) 2006-07-19
MXPA06013321A (es) 2007-02-02
AU2005247588A1 (en) 2005-12-08
BRPI0511523A (pt) 2007-12-26
EP1761525B1 (de) 2008-07-23
JP2008500298A (ja) 2008-01-10
US7005526B2 (en) 2006-02-28
US20050267179A1 (en) 2005-12-01
CA2565257A1 (en) 2005-12-08
DE602005008433D1 (de) 2008-09-04
RU2006145895A (ru) 2008-06-27
EP1761525A1 (de) 2007-03-14

Similar Documents

Publication Publication Date Title
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
DE602005006815D1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
DE602005002470D1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
EP2030974A4 (de) Heterozyklische nichtnukleosidverbindungen, ihre herstellung, pharmazeutische zusammensetzung und ihre verwendung als antivirale mittel
ATE469152T1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
DE502005002105D1 (de) 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln
ATE524178T1 (de) Acylierte, heteroaryl-kondensierte cycloalkenylamine und deren verwendung als arzneimittel
ATE353900T1 (de) Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
DE602004027932D1 (de) Benzimidazolderivate: herstellung und pharmazeutische anwendungen
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
ATE420084T1 (de) Neue imidazolderivate und deren verwendung als pharmazeutische mittel
DE502005006424D1 (de) Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
DE60323754D1 (de) Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung
ATE512970T1 (de) Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
ATE502035T1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
DE602004030564D1 (de) 2-substituierte phenyl-5,7-dialkyl-3,7-dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung
DE602005019743D1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
DE602004015600D1 (de) Neue imidazolderivative, deren herstellung und deren verwendung als medikament
ATE417846T1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
ATE542806T1 (de) Diarylmethylpiperazinderivate, deren herstellung und deren verwendung
ATE409190T1 (de) Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel
DE602004022169D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DE602006005246D1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
DE602004020063D1 (de) Pyrido[2,3-d] pyrimidin-7-carbonsäurederivate, deren herstellung und deren verwendung als pharmazeutische mittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties